S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

XGN Exagen Inc

5.28

0.33 (6.67%)

Last Updated: 13:31:09

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Exagen (NASDAQ:XGN)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Exagen Charts.

Exagen (NASDAQ:XGN)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Exagen Charts.

Exagen Inc News

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 12 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD
Thursday 12 December 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 27 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 19 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 18 November 2024 (1 month ago) • Edgar (US Regulatory)

Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform
Thursday 14 November 2024 (1 month ago) • GlobeNewswire Inc.

Exagen Inc. to Participate in Fourth Quarter Investor Conferences
Wednesday 13 November 2024 (1 month ago) • GlobeNewswire Inc.

Exagen Inc. Reports Third Quarter 2024 Results
Tuesday 12 November 2024 (1 month ago) • GlobeNewswire Inc.

Exagen to Announce Third Quarter 2024 Results on November 12, 2024
Tuesday 29 October 2024 (2 months ago) • GlobeNewswire Inc.

Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence
Monday 21 October 2024 (2 months ago) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Tuesday 8 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 4 September 2024 (4 months ago) • Edgar (US Regulatory)

More Exagen Inc News Articles

Hallmark Venture (PK)

Virexit Technologies (PK)

ELine Entertainment (CE)

Asia Broadband (PK)

Intergrated Cannabis Sol... (PK)

Anavex Life Sciences

KULR Technology

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions